Logo 202 Logo 202 (Methylphenidate hydrochloride extended-release 40 mg)

Pill imprint Logo 202 Logo 202 has been identified as Methylphenidate hydrochloride extended-release 40 mg.

Methylphenidate is used in the treatment of adhd; narcolepsy; obesity; depression; fatigue (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.

See also related documents.

Images for Logo 202 Logo 202 (Methylphenidate hydrochloride extended-release 40 mg)

Methylphenidate hydrochloride extended-release 40 mg Logo 202 Logo 202
Methylphenidate hydrochloride extended-release
Logo 202
Logo 202
40 mg
White / Blue
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Actavis South Atlantic LLC

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)